Results 181 to 190 of about 3,725 (244)
ABSTRACT Background Skin aging is a complex process influenced by genetic, hormonal, and environmental factors. Exosome‐based therapies, particularly those derived from plant sources such as apples, have emerged as a promising alternative for promoting skin regeneration and improving skin health.
Yong Xun Jin +16 more
wiley +1 more source
Movement Disorders Clinical Practice, Volume 13, Issue 11, Page 3134-3136, November 2026.
Shohei Okusa +8 more
wiley +1 more source
DIHYDROXYPHENYLALANINE, A CONSTITUENT OF THE VELVET BEAN
openaire +1 more source
ENZYMATIC DECARBOXYLATION OF 2,6- AND 2,3-DIHYDROXYPHENYLALANINE
The action of dihydroxyphenylalanine (dopa) decarboxylase of guinea pig kidney and of tyrosine decarboxylase of Streptococcus faecalis R on 2,3- and 2,6-dopa has been studied. Compared with 3,4-dopa, these substrates are decarboxylated by the kidney enzyme at rates decreasing in the order: 2,3-, 3,4-, 2,6-dopa.
Theodore L. Sourkes
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Neurochemistry, 1981
Abstract: We have investigated the effects of 3,4‐dihydroxyphenylalanine l‐DOPA) and its deuterated analogue on the concentrations of alcoholic metabolites of catecholamines in rat brain by means of gas chromatography/mass spectrometry with selected‐ion monitoring.
David J Edwards
exaly +3 more sources
Abstract: We have investigated the effects of 3,4‐dihydroxyphenylalanine l‐DOPA) and its deuterated analogue on the concentrations of alcoholic metabolites of catecholamines in rat brain by means of gas chromatography/mass spectrometry with selected‐ion monitoring.
David J Edwards
exaly +3 more sources
An Actinomycete Producing L-3,4-Dihydroxyphenylalanine From L-Tyrosine [PDF]
An actinomycete was isolated during a soil screening programme to obtain L-3,4-dihydroxyphenylalanine producers. A mutant of this organism was isolated by chemical mutagenesis and it accumulated 1 g/litre L-dihydroxyphenylalanine when grown on L-tyrosine.
P R Mahadevan
exaly +2 more sources
The aim of this study was to perform a meta-analysis of published data about the diagnostic performance of (18)F-dihydroxyphenylalanine (DOPA) positron emission tomography (PET) or PET/computed tomography (CT) in detecting recurrent medullary thyroid ...
Giorgio Treglia +2 more
exaly +2 more sources
Dihydroxyphenylalanine in Extrapyramidal Disease
JAMA: The Journal of the American Medical Association, 1963EVIDENCE has been accumulating for the past several years which has implicated dopamine metabolism in the production of extrapyramidal symptoms. Drugs such as reserpine which tend to produce extrapyramidal symptoms as a side effect have been shown to deplete dopamine from the brain.
A J, FRIEDHOFF +3 more
openaire +2 more sources
Neuronal Source of Plasma Dihydroxyphenylalanine
The Journal of Clinical Endocrinology & Metabolism, 1987The source and significance of plasma levels of dihydroxyphenylalanine (DOPA), the precursor of the endogenous catecholamines, have been unknown. We measured arterial and venous plasma DOPA concentrations in healthy subjects at rest, patients who had undergone regional sympathectomies or were undergoing general anesthesia, and subjects during ...
DAVID S. GOLDSTEIN +6 more
openaire +2 more sources
Decarboxylation of 3,4-dihydroxyphenylalanine by oxyhemoglobin
Biochemical and Biophysical Research Communications, 1972Abstract A lysate of red blood cells catalyzes the decarboxylation of 3,4-dihydroxyphenylalanine. This activity appears to be due to a reaction with oxyhemoglobin and not the presence of aromatic L amino acid decarboxylase in erythrocytes.
H, Yamabe, W, Lovenberg
openaire +2 more sources

